Sanofi's Infilbray wins first approval for neurological symptoms of Gaucher
Sanofi won approval Wednesday for Infilbray, the first drug in the US to treat the neurological symptoms of a rare genetic disorder called Gaucher disease. Infilbray, also known as venglustat, crosses the blood-brain barrier to ...
comments(0)
5-min edit window · permanent after that